Medical care, treatment in case of failure, Centre de Preuves en Dermatologie

Guidelines cold urticaria Updated on Sep 24

Responsibility

The information provided by this website comes from sources deemed reliable. However, the Société Française de Dermatologie recommends that the user ensure the validity of this information. Some may prove to be erroneous or be subject to typos or display errors.

The use of this data is under the sole responsibility of the user. The Société Française de Dermatologie cannot be blamed for a misinterpretation of the data provided by the site, or in the event of erroneous information. This decision tree and all the contents of this site have been developed in the context of updated data from science according to the HAS methodology, expert opinions and reviewers of the various documents and in the context of the French healthcare system.

I have read and accept the general conditions of use of this website

Second-Line Treatment

Back to decision-making tree Print last updated on 20/12/2024

Second-Generation Anti-H1 Antihistamines

Increase up to 4 doses per day.

In Adults

In cases of cold-induced urticaria resistant to second-generation H1 antihistamines at conventional dosages, the working group recommends increasing the dosage up to four times the standard dose. The second-generation H1 antihistamines studied at dosages up to four times the conventional dose (for cold-induced urticaria) include bilastine, desloratadine, and rupatadine.

Regarding tolerance and by extension based on studies in chronic spontaneous urticaria, no more frequent or severe side effects have been observed at high doses compared to conventional dosage. The main reported side effects are drowsiness, dizziness, headaches, and nausea.

Pediatric Population

For children, the management algorithm for cold urticaria is similar to that of adults, with first-line treatment using a second-generation anti-H1 antihistamine at conventional dosage. As a second-line treatment, the working group recommends increasing the dosage up to four times the standard dose of second-generation anti-H1 antihistamines, with a preference for desloratadine, which has been studied at double, triple, and quadruple doses in chronic spontaneous urticaria, demonstrating good tolerance.

➜ Table of main antihistamines used in the pediatric population

Was this article helpful to you?
Your opinion counts!

This notice will not be published on this site, but only sent to the publication management. Your email will only be used to reply to you if we deem it necessary. No response will be sent to any request for medical advice via this form.